Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tonix Pharmaceuticals

13.47
+0.45003.46%
Post-market: 13.32-0.1526-1.13%19:59 EDT
Volume:2.28M
Turnover:33.01M
Market Cap:75.30M
PE:-1.73
High:15.90
Open:13.68
Low:13.29
Close:13.02
Loading ...

Tonix Pharmaceuticals Gets FDA Review of Fibromyalgia Drug

Dow Jones
·
17 Dec 2024

Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (Nda) for Tnx-102 Sl for Fibromyalgia

THOMSON REUTERS
·
17 Dec 2024

Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia

GlobeNewswire
·
17 Dec 2024

Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights

GlobeNewswire
·
17 Dec 2024

Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers

ACCESSWIRE
·
09 Dec 2024

Tonix Pharmaceuticals appoints Raudabaugh, Gould as VPs

TIPRANKS
·
03 Dec 2024

Tonix Pharmaceuticals Announces Expansion of Leadership Team With Two Strategic Hires

THOMSON REUTERS
·
03 Dec 2024

Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic Hires

GlobeNewswire
·
03 Dec 2024

TNXP: NDA Filed for TNX-102 SL in Fibromyalgia…

Zacks Small Cap Research
·
03 Dec 2024

Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference

GlobeNewswire
·
26 Nov 2024

Top Premarket Gainers

MT Newswires Live
·
20 Nov 2024

Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual

GlobeNewswire
·
19 Nov 2024

Tonix Pharmaceuticals presents data, analyses of TNX-102 SL effects

TIPRANKS
·
18 Nov 2024

Press Release: Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

Dow Jones
·
18 Nov 2024

Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments

ACCESSWIRE
·
14 Nov 2024

Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

GlobeNewswire
·
14 Nov 2024